inhibit aortic connective tissue remodeling after plasma lipid lowering in
female monkeys. Arterioscler Thromb Vasc Biol 18:1164 –1171
7. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, 32.
Clarkson TB 1990 Inhibition of coronary artery atherosclerosis by 17- estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. 33.
Arteriosclerosis 10:1051–1057
8. Rosano GM, Webb CM, Chierchia S, Morgani GL, Gabraele M, Sarrel PM, de 34.
Ziegler D, Collins P 2000 Natural progesterone, but not medroxyprogesterone
acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial 35.
ischemia in postmenopausal women. J Am Coll Cardiol 36:2154 –2159
9. Nilsen J, Brinton RD 2002 Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism 36.
by medroxyprogesterone acetate. Endocrinology 143:205–212
10. Nilsen J, Brinton RD 2003 Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase 37.
signaling. Proc Natl Acad Sci USA 100:10506 –10511
11. Speroff L, Glass RH, Kase NG 1999 Clinical gynecologic endocrinology and
infertility. 6th ed. Baltimore: Lippincott Williams & Wilkins 38.
12. Hiroi M, Stanczyk FZ, Goebelsmann U, Brenner PF, Lumkin ME, Mishell Jr
DR 1975 Radioimmunoassay of serum medroxyprogesterone acetate (Provera)
in women following oral and intravaginal administration. Steroids 26:373–386 39.
13. Sitruk-Ware R 2004 Pharmacological profile of progestins. Maturitas 47:
277–283 40.
14. Ross R 1999 Atherosclerosis: an inflammatory disease. N Engl J Med 340:
115–126
15. Xing D, Miller A, Novak L, Rocha R, Chen YF, Oparil S 2004 Estradiol and
progestins differentially modulate leukocyte infiltration after vascular injury. 41.
Circulation 109:234 –241
16. Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kishimoto T, Kasayama
S 2001 Progesterone, but not medroxyprogesterone, inhibits vascular cell ad- hesion molecule-1 expression in human vascular endothelial cells. Arterioscler
Thromb Vasc Biol 21:243–248 42.
17. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Genazzani AR 2003
In vitro effects of progesterone and progestins on vascular cells. Steroids
68:831– 836 43.
18. Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, Lanzone A,
Genazzani AR, Petraglia F 1999 Human umbilical vein endothelial cells: a new
source and potential target for corticotropin-releasing factor. J Clin Endocrinol
Metab 84:2802–2806 44.
19. Knowles RG, Salter M 1998 Measurement of NOS activity by conversion of
radiolabeled arginine to citrulline using ion-exchange separation. In: Titheradge MA, ed. Nitric oxide protocols. Totowa, NJ: Humana Press; 67–73 45.
20. Simoncini T, Genazzani AR 2000 Raloxifene acutely stimulates nitric oxide
release from human endothelial cells via an activation of endothelial nitric
oxide synthase. J Clin Endocrinol Metab 85:2966 –2969 46.
21. Simoncini T, Hafezi-Moghadam A, Brazil D, Ley K, Chin WW, Liao JK 2000
Interaction of estrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538 –541
22. Simoncini T, Maffei S, Basta G, Barsacchi G, Genazzani AR, Liao JK, De 47.
Caterina R 2000 Estrogens and glucocorticoids inhibit endothelial vascular cell
adhesion molecule-1 expression by different transcriptional mechanisms. Circ
Res 87:19 –25 48.
23. Pober J, Gimbrone MJ, Lapierre L, Mendrick D, Fiers W, Rothlein R,
Springer T 1986 Overlapping patterns of activation of human endothelial cells
by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol
137:1893–1896 49.
24. Dignam JD, Lebovitz RM, Roeder RG 1983 Accurate transcription initiation
by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
Nucleic Acids Res 11:1475–1489 50.
25. Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T 1992 Functional
analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med
176:1583–1593
26. Kloosterboer HJ, Deckers GH, Schoonen WG 1994 Pharmacology of two new 51.
very selective antiprogestogens: Org 31710 and Org 31806. Hum Reprod
9(Suppl 1):47–52
27. Simoncini T, Varone G, Fornari L, Mannella P, Luisi M, Labrie F, Genazzani
AR 2002 Genomic and nongenomic mechanisms of nitric oxide synthesis
induction in human endothelial cells by a fourth-generation selective estrogen 52.
receptor modulator. Endocrinology 143:2052–2061
28. Simoncini T, Genazzani AR 2003 Non-genomic actions of sex steroid hormones. Eur J Endocrinol 148:281–292
29. Simoncini T, Rabkin E, Liao JK 2003 Molecular basis of cell membrane 53.
estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial
cells. Arterioscler Thromb Vasc Biol 23:198 –203
30. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM 1999
Activation of nitric oxide synthase in endothelial cells by Akt-dependent 54.
phosphorylation. Nature 399:601– 605
Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF,
